GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
6ZE7 | 6ZE7 | Chaetomium thermophilum FAD-dependent oxidoreductase in complex with 4-nitrophenol | |
6ZE6 | 6ZE6 | FAD-dependent oxidoreductase from Chaetomium thermophilum in complex with fragment 4-nitrocatechol | |
6ZE5 | 6ZE5 | FAD-dependent oxidoreductase from Chaetomium thermophilum in complex with fragment 2-(1H-indol-3-yl)-N-[(1-methyl-1H-pyrrol-2-yl)methyl]ethanamine | |
6ZE4 | 6ZE4 | FAD-dependent oxidoreductase from Chaetomium thermophilum in complex with fragment 4-oxo-N-[(1S)-1-(pyridin-3-yl)ethyl]-4-(thiophen-2-yl)butanamide | |
6ZE3 | 6ZE3 | FAD-dependent oxidoreductase from Chaetomium thermophilum in complex with fragment (4-methoxycarbonylphenyl)methylazanium | |
6ZE2 | 6ZE2 | FAD-dependent oxidoreductase from Chaetomium thermophilum | |
6ZDX | Q8I4N9 | RIFIN variable region bound to LILRB1 ectodomain | |
6ZDX | A0A0G2JQ46 | RIFIN variable region bound to LILRB1 ectodomain | |
6ZDM | Q9Y251 | Crystal structure of human heparanase in complex with a N',6O'-bis-sulfated 4-methylumbelliferyl heparan sulfate disaccharide | |
6ZDL | Q5SRI9 | Structure of the catalytic domain of human endo-alpha-mannosidase MANEA in complex with GlcIFG and hexatungstotellurate(VI) TEW | |
6ZDH | P0DTC2 | SARS-CoV-2 Spike glycoprotein in complex with a neutralizing antibody EY6A Fab | |
6ZDH | 6ZDH | SARS-CoV-2 Spike glycoprotein in complex with a neutralizing antibody EY6A Fab | |
6ZDG | P0DTC2 | Association of three complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab | |
6ZDG | 6ZDG | Association of three complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab | |
6ZCZ | P0DTC2 | Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in ternary complex with EY6A Fab and a nanobody. | |
6ZCZ | 6ZCZ | Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in ternary complex with EY6A Fab and a nanobody. | |
6ZBX | Q9Z4P9 | Structure of the catalytic domain of the Bacillus circulans alpha-1,6 Mannanase in complex with an alpha-1,6- alpha-manno-cyclophellitol carbasugar-stabilised trisaccharide inhibitor | |
6ZBX | 6ZBX | Structure of the catalytic domain of the Bacillus circulans alpha-1,6 Mannanase in complex with an alpha-1,6- alpha-manno-cyclophellitol carbasugar-stabilised trisaccharide inhibitor | |
6ZBW | Q9Z4P9 | Structure of the D125N mutant of the catalytic domain of the Bacillus circulans alpha-1,6 Mannanase in complex with an alpha-1,6-alpha-manno-cyclophellitol trisaccharide inhibitor | |
6ZBP | P0DTC2 | H11-H4 complex with SARS-CoV-2 | |
6ZBP | 6ZBP | H11-H4 complex with SARS-CoV-2 | |
6ZBM | Q9Z4P9 | Structure of the D125N mutant of the catalytic domain of the Bacillus circulans alpha-1,6 Mannanase in complex with an alpha-1,6-alpha-manno-cyclophellitol carbasugar-stabilised trisaccharide inhibitor | |
6ZB5 | P0DTC2 | SARS CoV-2 Spike protein, Closed conformation, C3 symmetry | |
6ZB4 | P0DTC2 | SARS CoV-2 Spike protein, Closed conformation, C1 symmetry | |
6ZAZ | Q8A6W4 | Fructo-oligosaccharide transporter BT 1762-63 | |
6ZAZ | Q8A6W3 | Fructo-oligosaccharide transporter BT 1762-63 | |
6ZAX | H0SLX7 | Nitrite-bound copper nitrite reductase from Bradyrhizobium sp. ORS 375 (two-domain) at low dose (0.5 MGy) | |
6ZAW | H0SLX7 | Damage-free NO-bound copper nitrite reductase from Bradyrhizobium sp. ORS 375 (two-domain) determined by serial femtosecond rotation crystallography | |
6ZAV | H0SLX7 | NO-bound copper nitrite reductase from Bradyrhizobium sp. ORS 375 (two-domain) at 1.19 A resolution (unrestrained, full matrix refinement by SHELX) | |
6ZAU | H0SLX7 | Damage-free nitrite-bound copper nitrite reductase from Bradyrhizobium sp. ORS 375 (two-domain) determined by serial femtosecond rotation crystallography | |
6Z9A | Q8A6W4 | Fructo-oligosaccharide transporter BT 1762-63 | |
6Z9A | Q8A6W3 | Fructo-oligosaccharide transporter BT 1762-63 | |
6Z97 | P10104 | Structure of the prefusion SARS-CoV-2 spike glycoprotein | |
6Z97 | P0DTC2 | Structure of the prefusion SARS-CoV-2 spike glycoprotein | |
6Z8L | P04746 | Alpha-Amylase in complex with probe fragments | |
6Z8H | Q58NS4 | Crystal structure of Variant Surface Glycoprotein VSG13 | |
6Z8G | Q58NS4 | Crystal structure of VSG13 soaked in 0.5 M used to phase VSG13 to solve the structure. | |
6Z7P | P35828 | Composite model of the Caulobacter crescentus S-layer bound to the O-antigen of lipopolysaccharide | |
6Z7E | A0A291L8F4 | Variant Surface Glycoprotein VSGsur mutant H122A soaked in 7.7 mM suramin | |
6Z7D | A0A291L8F4 | Variant Surface Glycoprotein VSGsur mutant H122A soaked in 0.77 mM Suramin. | |
6Z7C | A0A291L8F4 | Variant Surface Glycoprotein VSGsur mutant H122A | |
6Z7B | A0A291L8F4 | Variant Surface Glycoprotein VSGsur bound to suramin | |
6Z7A | A0A291L8F4 | Variant Surface Glycoprotein VSGsur | |
6Z79 | A0A291L8F4 | Variant Surface Glycoprotein VSGsur, I3C ("Magic Triangle") derivative used for phasing of the structure and subsequently as a model for molecular replacement of native, mutants, and drug soaks. | |
6Z6V | P02745 | Globular head of C1q in complex with the nanobody C1qNb75 | |
6Z6V | P02746 | Globular head of C1q in complex with the nanobody C1qNb75 | |
6Z6V | P02747 | Globular head of C1q in complex with the nanobody C1qNb75 | |
6Z6V | 6Z6V | Globular head of C1q in complex with the nanobody C1qNb75 | |
6Z62 | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, P213 form, TRIS-HCl pH 8.5 | |
6Z60 | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, P213 form, CAPS pH 9.5 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024